Myeloid-derived suppressor cells in colorectal cancer: prognostic biomarkers and therapeutic targets
Myeloid-derived suppressor cells (MDSCs) are a group of immature myeloid cells, which are expanded in most cancer patients. MDSCs suppress host immune responses, leading to cancer growth and progression. Several studies demonstrated that there was a relationship between levels of MDSCs and tumorigen...
Saved in:
Main Authors: | Mohammad A. Al-Mterin (Author), Eyad Elkord (Author) |
---|---|
Format: | Book |
Published: |
Open Exploration Publishing Inc.,
2022-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Myeloid-Derived Suppressor Cells and Therapeutic Strategies in Cancer
by: Hiroshi Katoh, et al.
Published: (2015) -
Novel therapeutic strategies targeting myeloid-derived suppressor cell immunosuppressive mechanisms for cancer treatment
by: Eric Jou, et al.
Published: (2024) -
Myeloid-derived suppressor cells: key immunosuppressive regulators and therapeutic targets in hematological malignancies
by: Shifen Wang, et al.
Published: (2023) -
Myeloid Derived Suppressor Cells as Disease Modulators
Published: (2020) -
The Role and Potential Therapeutic Application of Myeloid-Derived Suppressor Cells in Allo- and Autoimmunity
by: Qi Zhang, et al.
Published: (2015)